Device Studies

Latest Headlines

Latest Headlines

VA starts trial of mobile app to help manage PTSD symptoms

The Department of Veterans Affairs is assessing the efficacy of a mobile application to teach patients to self-manage post-traumatic stress disorder (PTSD). The trial is set up to determine the relative advantage of the app in combination with physician support versus its use alone.

Study: OvaScience fertility treatment improves pregnancy rates, but Wall Street remains skeptical

Pregnancy rates were higher than might normally be expected with in vitro fertilization in the latest data for the Augment Fertility Treatment from OvaScience. But fertilization and blastocyst formation weren't particularly improved. Even the pregnancy rates don't look quite so good--when you consider all the patients who originally enrolled, noted a Leerink analyst.

TVA study demonstrates promising hemodialysis access device for kidney failure patients

Startup TVA Medical boasted about a recent study which found that its clinical-stage device to give chronic kidney disease patients vascular access to a hemodialysis machine was successful 97% of the time.

Medtronic, Novartis back implantable beta cell diabetes device in $44M Series A, partnership

Semma Therapeutics aims to provide beta cells--the pancreatic cells that produce insulin--to patients with Type 1 diabetes. If the startup can get beyond early research, an implantable device that creates insulin via these stem cell-derived beta cells could replace daily insulin injections and transform patient care.

JAMA study not supportive of use of stents in patients at risk of stroke

A study just published in the Journal of the American Medical Association found that among patients with intracranial arterial stenosis (narrowing of an artery inside the brain), the use of a stent resulted in an increased risk of stroke in comparison to medications.

Registry data to be shared at meeting of orthopedic surgeons

At the American Academy of Orthopedic Surgeons' annual meeting, which commences tomorrow, findings from the most comprehensive data registry of total hip and knee replacements will be revealed. Dubbed FORCE-TJR, the registry of 30,000-plus patients includes information about risk factors, patient-reported measures of pain, clinical measures like readmission, infection rates, adverse events, and more.

Study: U.S. healthcare reform has led to a diabetes diagnosis surge in states with Medicaid expansion

The enactment of the Affordable Care Act with its expansion of Medicaid benefits has led to an uptick in diabetes diagnoses by almost one-quarter, according to a study of deidentified test results from Quest Diagnostics. That's in states that opted to expand Medicaid under the new law during the first 6 months of 2014 as compared to the first 6 months of 2013.

Edwards-backed CardioKinetix reports China heart failure data; U.S. pivotal results expected in 2016

Startup CardioKinetix has reported positive pivotal data from China on its catheter-based heart failure treatment, the Parachute Ventricular Partitioning Device. It expects these study results to support a regulatory submission with the China Food and Drug Administration.

Study: Newest drug-coated stents as effective as bypass surgery in coronary artery disease

The catheter-based insertion of one of the latest generation of drug-coated stents is just as effective as bypass surgery in treating coronary artery disease, according to a study in the latest issue of the New England Journal of Medicine. That was not the case with the prior generations of bare metal or first-generation drug-eluting stents.

Registry data shows Abbott's MitraClip transcatheter valve is performing well in real-world settings

Experts at the annual meeting of the American College of Cardiology in San Diego said postmarket registry data collected on Abbott's MitraClip to enable less invasive transcatheter mitral valve repair shows that the device is safe and effective, in line with premarket clinical trial data.